Stephen Yoo, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 37,128 shares at $69.97 ($2.5M) on 2018-11-05, disclosed to the SEC on 2018-11-07.
Open-market sale of $2.5M RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.26 | 3,413 | $226K | 8.9% |
| 2 | $66.26 | 3,413 | $226K | 8.9% |
| 3 | $67.14 | 4,820 | $324K | 12.8% |
| 4 | $67.14 | 4,820 | $324K | 12.8% |
| 5 | $68.22 | 3,700 | $252K | 10.0% |
| 6 | $69.54 | 3,854 |
| $268K |
| 10.6% |
| 7 | $69.54 | 3,854 | $268K | 10.6% |
| 8 | $69.97 | 4,627 | $324K | 12.8% |
| 9 | $69.97 | 4,627 | $324K | 12.8% |
| Total | $68.29 avg | 37,128 | $2.5M | 100% |
| Filing → |
| RGNX | SELL | 2018-10-31 | $2.3M | — | Filing → |
| RGNX | SELL | 2018-10-17 | $1.9M | — | Filing → |
| RGNX | SELL | 2017-09-12 | $684K | — | Filing → |